P7T-25516-25883
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 402 / KY
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-30
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain — Feeling: Fair · Site: Pain · HeadacheFree text: Ocular painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2022-01-05
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Cough, Headache, Myalgia, Obesity, Patient isolation, Pregnancy, Pyrexia, SARS-CoV-2 test positive, Vomiting — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for covidcough, headache, myalgias, fever, vomiting, loss of taste and smell. Was isolated x 10 days. Got regeneron because I was pregnant and obeseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Ocular pain
Release 10 — 12 months, dose 2
Symptoms: Tested positive for covidcough, headache, myalgias, fever, vomiting, loss of taste and smell. Was isolated x 10 days. Got regeneron because I was pregnant and obese
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Obesity | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release